Condensed Statements of Stockholders' Equity - USD ($) $ in Thousands	Common Stock [Member]	Additional Paid-in Capital [Member]	Accumulated Deficit [Member]	Accumulated Other Comprehensive Income (Loss) [Member]	Total
Beginning balance (in shares) at Dec. 31, 2021	34,980,896
Beginning balance at Dec. 31, 2021	$ 35	$ 367,907	$ (288,702)		$ 79,240
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		168			168
Exercise of stock options (in shares)	35,453
Issuance of common stock upon vesting of restricted stock units (in shares)	57,253
Stock-based compensation		4,978			4,978
Net loss			(16,679)		(16,679)
Ending balance (in shares) at Mar. 31, 2022	35,073,602
Ending balance at Mar. 31, 2022	$ 35	373,053	(305,381)		67,707
Beginning balance (in shares) at Dec. 31, 2021	34,980,896
Beginning balance at Dec. 31, 2021	$ 35	367,907	(288,702)		79,240
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net loss					(42,396)
Ending balance (in shares) at Sep. 30, 2022	35,381,085
Ending balance at Sep. 30, 2022	$ 35	388,452	(331,098)	$ (191)	57,198
Beginning balance (in shares) at Mar. 31, 2022	35,073,602
Beginning balance at Mar. 31, 2022	$ 35	373,053	(305,381)		67,707
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		322			322
Exercise of stock options (in shares)	55,941
Issuance of common stock upon vesting of restricted stock units (in shares)	13,075
Issuance of common stock under employee stock purchase plan		1,239			1,239
Issuance of common stock under employee stock purchase plan (in shares)	50,551
Stock-based compensation		6,161			6,161
Net loss			(15,398)		(15,398)
Unrealized gain (loss) on investments, net				(2)	(2)
Ending balance (in shares) at Jun. 30, 2022	35,193,169
Ending balance at Jun. 30, 2022	$ 35	380,775	(320,779)	(2)	60,029
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		1,338			1,338
Exercise of stock options (in shares)	161,924
Issuance of common stock upon vesting of restricted stock units (in shares)	25,992
Stock-based compensation		6,339			6,339
Net loss			(10,319)		(10,319)
Unrealized gain (loss) on investments, net				(189)	(189)
Ending balance (in shares) at Sep. 30, 2022	35,381,085
Ending balance at Sep. 30, 2022	$ 35	388,452	(331,098)	(191)	57,198
Beginning balance (in shares) at Dec. 31, 2022	38,355,972
Beginning balance at Dec. 31, 2022	$ 38	507,715	(343,712)	(166)	163,875
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		1,110			1,110
Exercise of stock options (in shares)	144,474
Issuance of common stock upon vesting of restricted stock units	$ 1				1
Issuance of common stock upon vesting of restricted stock units (in shares)	207,995
Stock-based compensation		8,838			8,838
Net loss			(16,460)		(16,460)
Unrealized gain (loss) on investments, net				249	249
Ending balance (in shares) at Mar. 31, 2023	38,708,441
Ending balance at Mar. 31, 2023	$ 39	517,663	(360,172)	83	157,613
Beginning balance (in shares) at Dec. 31, 2022	38,355,972
Beginning balance at Dec. 31, 2022	$ 38	507,715	(343,712)	(166)	$ 163,875
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options (in shares)					195,708
Net loss					$ (42,732)
Ending balance (in shares) at Sep. 30, 2023	38,907,789
Ending balance at Sep. 30, 2023	$ 39	539,831	(386,444)	(284)	153,142
Beginning balance (in shares) at Mar. 31, 2023	38,708,441
Beginning balance at Mar. 31, 2023	$ 39	517,663	(360,172)	83	157,613
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		232			232
Exercise of stock options (in shares)	32,483
Issuance of common stock upon vesting of restricted stock units (in shares)	19,400
Issuance of common stock under employee stock purchase plan		1,359			1,359
Issuance of common stock under employee stock purchase plan (in shares)	51,956
Stock-based compensation		10,199			10,199
Net loss			(13,484)		(13,484)
Unrealized gain (loss) on investments, net				(414)	(414)
Ending balance (in shares) at Jun. 30, 2023	38,812,280
Ending balance at Jun. 30, 2023	$ 39	529,453	(373,656)	(331)	155,505
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Exercise of stock options		131			131
Exercise of stock options (in shares)	18,751
Issuance of common stock upon vesting of restricted stock units (in shares)	76,758
Stock-based compensation		10,247			10,247
Net loss			(12,788)		(12,788)
Unrealized gain (loss) on investments, net				47	47
Ending balance (in shares) at Sep. 30, 2023	38,907,789
Ending balance at Sep. 30, 2023	$ 39	$ 539,831	$ (386,444)	$ (284)	$ 153,142